Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,022 INR | +2.26% | -2.91% | +19.76% |
05-03 | Glenmark Pharmaceuticals Limited Appoints Shweta Munjal as Chief Communications & CSR Officer | CI |
04-29 | Glenmark Pharmaceuticals Gets US FDA's Final Approval for Generic Pain Relief Medicines | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+19.76% | 3.38B | |
+19.27% | 42.97B | |
+24.52% | 22.49B | |
+16.41% | 14.93B | |
+11.48% | 13.14B | |
+42.79% | 11.67B | |
-8.84% | 6.86B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.13% | 5.54B |
- Stock Market
- Equities
- GLENMARK Stock
- News Glenmark Pharmaceuticals Limited
- Glenmark Pharma Launches Diabetes Control Drug in India